Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: HO-Metabolic Labeling-Based Kinetic Approach
Overview
Chemistry
Molecular Biology
Affiliations
Mice fed a high-fat diet for 12 weeks or longer develop hyperglycemia, insulin resistance, dyslipidemia, and fatty liver. Additionally, a high-fat diet induces inflammation that remodels and affects the anti-inflammatory and antiatherogenic property of the high-density lipoprotein (HDL). However, the precise time course of metabolic disease progression and HDL remodeling remains unclear. Short-term (four weeks) high-fat feeding (60% fat calories) was performed in wild-type male C57BL/6J mice to gain insights into the early metabolic disease processes in conjunction with a HDL proteome dynamics analysis using a heavy water metabolic labeling approach. The high-fat diet-fed mice developed hyperglycemia, impaired glucose tolerance, hypercholesterolemia without hypertriglyceridemia or hepatic steatosis. A plasma HDL proteome dynamics analysis revealed increased turnover rates (and reduced half-lives) of several acute-phase response proteins involved in innate immunity, including complement C3 (12.77 ± 0.81 vs. 9.98 ± 1.20 h, < 0.005), complement factor B (12.71 ± 1.01 vs. 10.85 ± 1.04 h, < 0.05), complement Factor H (19.60 ± 1.84 vs. 16.80 ± 1.58 h, < 0.05), and complement factor I (25.25 ± 1.29 vs. 19.88 ± 1.50 h, < 0.005). Our findings suggest that an early immune response-induced inflammatory remodeling of the plasma HDL proteome precedes the diet-induced steatosis and dyslipidemia.
Measuring HSD17β13 protein turnover in mouse liver with DO metabolic labeling and hybrid LC-MS.
Shi Y, Del Rosario A, Wang S, Kang L, Liu H, Rady B Bioanalysis. 2025; 17(3):151-159.
PMID: 39819243 PMC: 11853646. DOI: 10.1080/17576180.2025.2452757.
Charlot A, Bringolf A, Mallard J, Charles A, Niederhoffer N, Duteil D Front Nutr. 2024; 11:1366883.
PMID: 38571752 PMC: 10987868. DOI: 10.3389/fnut.2024.1366883.
SARS-CoV-2 induced HDL dysfunction may affect the host's response to and recovery from COVID-19.
Al-Kuraishy H, Hussien N, Al-Niemi M, Fahad E, Al-Buhadily A, Al-Gareeb A Immun Inflamm Dis. 2023; 11(5):e861.
PMID: 37249296 PMC: 10187021. DOI: 10.1002/iid3.861.
Zhao J, Wu Y, Lu P, Wu X, Han J, Shi Y Front Immunol. 2022; 13:1054159.
PMID: 36569882 PMC: 9782972. DOI: 10.3389/fimmu.2022.1054159.
Sadana P, Edler M, Aghayev M, Arias-Alvarado A, Cohn E, Ilchenko S Am J Physiol Endocrinol Metab. 2022; 323(6):E480-E491.
PMID: 36223521 PMC: 9722254. DOI: 10.1152/ajpendo.00158.2022.